<table frame="void" id="AC708614-2996-4FCF-9CB7-274603DB8AFA" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1. Mean Percent Change in Lipid Parameters at End of Treatment<sup>†</sup></caption>
<thead>
<tr><td valign="top"><content stylecode="bold">Treatment Group</content></td><td align="center" valign="top"><content stylecode="bold">Total-C</content></td><td align="center" valign="top"><content stylecode="bold">LDL-C</content></td><td align="center" valign="top"><content stylecode="bold">HDL-C</content></td><td align="center" valign="top"><content stylecode="bold">TG</content></td></tr>
</thead>
<tfoot>
<tr><td colspan="5" valign="top"><sup>†</sup> Duration of study treatment was 3 to 6 months.</td></tr>
<tr><td colspan="5" valign="top">* p=&lt;0.05 vs. placebo</td></tr>
</tfoot>
<tbody>
<tr><td colspan="5" valign="top">Pooled Cohort</td></tr>
<tr><td valign="top">Mean baseline lipid values (n=646)</td><td align="center" valign="top">306.9 mg/dL</td><td align="center" valign="top">213.8 mg/dL</td><td align="center" valign="top">52.3 mg/dL</td><td align="center" valign="top">191.0 mg/dL</td></tr>
<tr><td valign="top">All FEN (n=361)</td><td align="center" valign="top">-18.7%*</td><td align="center" valign="top">-20.6%*</td><td align="center" valign="top">+11.0%*</td><td align="center" valign="top">-28.9%*</td></tr>
<tr><td stylecode="Botrule" valign="top">Placebo (n=285)</td><td align="center" stylecode="Botrule" valign="top">-0.4%</td><td align="center" stylecode="Botrule" valign="top">-2.2%</td><td align="center" stylecode="Botrule" valign="top">+0.7%</td><td align="center" stylecode="Botrule" valign="top">+7.7%</td></tr>
<tr><td colspan="5" stylecode="Toprule" valign="top">Baseline LDL-C &gt;160 mg/dL</td></tr>
<tr><td colspan="5" valign="top">and TG &lt;150 mg/dL (Type <content stylecode="bold">II</content>a)</td></tr>
<tr><td valign="top">Mean baseline lipid values (n=334)</td><td align="center" valign="top">307.7 mg/dL</td><td align="center" valign="top">227.7 mg/dL</td><td align="center" valign="top">58.1 mg/dL</td><td align="center" valign="top">101.7 mg/dL</td></tr>
<tr><td valign="top">All FEN (n=193)</td><td align="center" valign="top">-22.4%*</td><td align="center" valign="top">-31.4%*</td><td align="center" valign="top">+9.8%*</td><td align="center" valign="top">-23.5%*</td></tr>
<tr><td stylecode="Botrule" valign="top">Placebo (n=141)</td><td align="center" stylecode="Botrule" valign="top">+0.2%</td><td align="center" stylecode="Botrule" valign="top">-2.2%</td><td align="center" stylecode="Botrule" valign="top">+2.6%</td><td align="center" stylecode="Botrule" valign="top">+11.7%</td></tr>
<tr><td colspan="5" stylecode="Toprule" valign="top">Baseline LDL-C &gt;160 mg/dL</td></tr>
<tr><td colspan="5" valign="top">and TG≥150 mg/dL (Type <content stylecode="bold">II</content>b)</td></tr>
<tr><td valign="top">Mean baseline lipid values (n=242)</td><td align="center" valign="top">312.8 mg/dL</td><td align="center" valign="top">219.8 mg/dL</td><td align="center" valign="top">46.7 mg/dL</td><td align="center" valign="top">231.9 mg/dL</td></tr>
<tr><td valign="top">All FEN (n=126)</td><td align="center" valign="top">-16.8%*</td><td align="center" valign="top">-20.1%*</td><td align="center" valign="top">+14.6%*</td><td align="center" valign="top">-35.9%*</td></tr>
<tr><td valign="top">Placebo (n=116)</td><td align="center" valign="top">-3.0%</td><td align="center" valign="top">-6.6%</td><td align="center" valign="top">+2.3%</td><td align="center" valign="top">+0.9%</td></tr>
</tbody>
</table>